LOC100130698: A Drug Target / Disease Biomarker (G100130698)
LOC100130698: A Drug Target / Disease Biomarker
LOC100130698 is a protein that is expressed in various tissues throughout the body. It is a part of the heat shock protein (HSP) family, which are proteins that are expressed in high abundance in response to an increase in temperature. HSPs play a crucial role in maintaining cellular homeostasis and have been implicated in a wide range of cellular processes, including stress response, DNA damage repair, and cell survival.
LOC100130698 is of particular interest as a potential drug target because of its involvement in a number of cellular processes that are associated with a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, LOC100130698 has been shown to interact with a variety of small molecules, including drugs that are currently being used to treat these diseases.
One of the key functions of LOC100130698 is its role in the stress response pathway. This pathway is involved in a wide range of cellular processes that are essential for stress tolerance, including the regulation of ion homeostasis, protein folding, and DNA damage repair. LOC100130698 is shown to play a key role in the regulation of ion homeostasis, which is critical for maintaining the proper levels of intracellular ions and is essential for a wide range of cellular processes, including muscle contractions and nerve function.
In addition to its role in the stress response pathway, LOC100130698 is also involved in a number of other cellular processes that are associated with a variety of diseases. For example, LOC100130698 has been shown to be involved in the regulation of cell adhesion, which is critical for the development and maintenance of tissues and organs. LOC100130698 is also involved in the regulation of the cytoskeleton, which is responsible for the structure and function of cells.
In addition to its role in cellular processes, LOC100130698 is also of particular interest as a potential drug target because of its involvement in a number of diseases. For example, LOC100130698 is shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Additionally, LOC100130698 is also involved in the development and progression of autoimmune disorders, including rheumatoid arthritis and multiple sclerosis.
Furthermore, LOC100130698 has been shown to interact with a variety of small molecules that are currently being used to treat these diseases. For example, LOC100130698 has been shown to interact with drugs that are used to treat neurodegenerative diseases, including disease-modifying therapies (DMTs) that are designed to slow the progression of neurodegenerative diseases. Additionally, LOC100130698 has also been shown to interact with drugs that are used to treat autoimmune disorders, including corticosteroids and immunomodulatory drugs.
Overall, LOC100130698 is a protein that is of particular interest as a potential drug target due to its involvement in a wide range of cellular processes that are associated with a variety of diseases. Its involvement in the stress response pathway and its role in the regulation of ion homeostasis, cell adhesion, and the cytoskeleton make it a promising target for a variety of therapeutic approaches. Additionally, its interaction with small molecules that are currently being used to treat a wide range of diseases, including neurodegenerative and autoimmune disorders, makes it an even more promising target for drug development.
Protein Name: Uncharacterized LOC100130698
The "LOC100130698 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100130698 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC100130744 | LOC100130748 | LOC100130872 | LOC100130899 | LOC100130938 | LOC100130987 | LOC100130992 | LOC100131096 | LOC100131107 | LOC100131257 | LOC100131289 | LOC100131372 | LOC100131496 | LOC100131532 | LOC100131626 | LOC100131635 | LOC100131859 | LOC100131877 | LOC100131943 | LOC100132004 | LOC100132062 | LOC100132077 | LOC100132078 | LOC100132249 | LOC100132287 | LOC100132356 | LOC100132609 | LOC100132626 | LOC100132651 | LOC100132686 | LOC100132741 | LOC100132781 | LOC100132797 | LOC100133077 | LOC100133165 | LOC100133177 | LOC100133284 | LOC100133331 | LOC100133920 | LOC100134317 | LOC100134368 | LOC100134391 | LOC100134868 | LOC100190986 | LOC100233156 | LOC100240728 | LOC100240734 | LOC100240735 | LOC100271840 | LOC100272216 | LOC100272217 | LOC100286922 | LOC100287036 | LOC100287290 | LOC100287329 | LOC100287413 | LOC100287792 | LOC100287834 | LOC100287846 | LOC100287944 | LOC100288069 | LOC100288162 | LOC100288208 | LOC100288637 | LOC100288656 | LOC100289230 | LOC100289283 | LOC100289308 | LOC100289333 | LOC100289361 | LOC100289470 | LOC100289473 | LOC100289495 | LOC100289511 | LOC100289561 | LOC100289580 | LOC100289656 | LOC100293211 | LOC100294145 | LOC100335030 | LOC100419773 | LOC100420587 | LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585 | LOC100505664 | LOC100505715 | LOC100505716 | LOC100505841 | LOC100505912 | LOC100505915 | LOC100505978 | LOC100506023 | LOC100506071 | LOC100506076 | LOC100506124 | LOC100506207 | LOC100506236 | LOC100506274
